BDSI
Income statement / Annual
Last year (2021), BioDelivery Sciences International, Inc.'s total revenue was $166.70 M,
an increase of 6.54% from the previous year.
In 2021, BioDelivery Sciences International, Inc.'s net income was $84.86 M.
See BioDelivery Sciences International, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$166.70 M
|
$156.47 M
|
$111.39 M
|
$55.64 M
|
$61.99 M
|
$15.55 M
|
$48.23 M
|
$38.94 M
|
$11.36 M
|
$54.54 M
|
| Cost of Revenue |
$23.37 M |
$24.67 M |
$21.59 M |
$15.78 M |
$19.50 M |
$11.26 M |
$8.10 M |
$4.94 M |
$2.08 M |
$1.91 M |
| Gross Profit |
$143.33 M |
$131.81 M |
$89.80 M |
$39.86 M |
$42.49 M |
$4.29 M |
$40.13 M |
$34.01 M |
$9.27 M |
$52.63 M |
| Gross Profit Ratio |
0.86 |
0.84 |
0.81 |
0.72 |
0.69 |
0.28 |
0.83 |
0.87 |
0.82 |
0.96 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$4.90 M
|
$13.04 M
|
$18.88 M
|
$20.62 M
|
$34.29 M
|
$53.33 M
|
$35.37 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$58.60 M
|
$58.87 M
|
$49.35 M
|
$54.69 M
|
$38.46 M
|
$12.35 M
|
$10.21 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$106.21 M
|
$98.83 M
|
$86.06 M
|
$58.60 M
|
$58.87 M
|
$49.35 M
|
$54.69 M
|
$38.46 M
|
$12.35 M
|
$10.21 M
|
| Other Expenses |
$0.00 |
-$3,000.00 |
$4,000.00 |
-$14,000.00 |
-$26,000.00 |
$64,000.00 |
$25,000.00 |
-$295,000.00 |
-$210,242.00 |
$32,954.00 |
| Operating Expenses |
$106.21 M |
$98.83 M |
$86.06 M |
$63.51 M |
$71.91 M |
$68.22 M |
$75.31 M |
$72.75 M |
$65.68 M |
$45.57 M |
| Cost And Expenses |
$129.58 M |
$123.49 M |
$107.65 M |
$79.29 M |
$91.41 M |
$79.48 M |
$83.41 M |
$77.68 M |
$67.76 M |
$47.48 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$280,709.00 |
| Interest Expense |
$7.50 M |
$7.01 M |
$19.04 M |
$10.19 M |
$8.58 M |
$3.27 M |
$2.52 M |
$2.02 M |
$902,658.00 |
$0.00 |
| Depreciation &
Amortization |
$7.42 M
|
$7.52 M
|
$8.83 M
|
$5.90 M
|
$6.12 M
|
$1.41 M
|
$1.30 M
|
$1.10 M
|
$1.35 M
|
$1.49 M
|
| EBITDA |
$44.54 M
|
$40.50 M
|
$12.57 M
|
-$17.77 M
|
$4.01 M
|
-$62.46 M
|
-$33.86 M
|
-$51.11 M
|
-$55.14 M
|
$8.58 M
|
| EBITDA Ratio |
0.27 |
0.26 |
0.11 |
-0.32 |
-0.38 |
-4.02 |
-0.7 |
-0.97 |
-4.87 |
0.16 |
| Operating Income Ratio
|
0.22
|
0.21
|
0.03
|
-0.43
|
-0.47
|
-4.11
|
-0.73
|
-0.99
|
-4.97
|
0.13
|
| Total Other
Income/Expenses Net |
-$7.50 M
|
-$7.02 M
|
-$19.04 M
|
-$10.21 M
|
$18.73 M
|
-$3.20 M
|
-$2.49 M
|
-$15.48 M
|
-$991,672.00
|
-$5.28 M
|
| Income Before Tax |
$29.62 M |
$25.96 M |
-$15.30 M |
-$33.85 M |
-$10.69 M |
-$67.14 M |
-$37.67 M |
-$54.22 M |
-$57.39 M |
$1.78 M |
| Income Before Tax Ratio
|
0.18
|
0.17
|
-0.14
|
-0.61
|
-0.17
|
-4.32
|
-0.78
|
-1.39
|
-5.05
|
0.03
|
| Income Tax Expense |
-$55.24 M |
$252,000.00 |
$5,000.00 |
$13,000.00 |
-$15.97 M |
$64,000.00 |
$25,000.00 |
-$13.46 M |
-$89,014.00 |
$129,120.00 |
| Net Income |
$84.86 M |
$25.71 M |
-$15.31 M |
-$33.87 M |
$5.29 M |
-$67.14 M |
-$37.67 M |
-$54.22 M |
-$57.39 M |
$1.65 M |
| Net Income Ratio |
0.51 |
0.16 |
-0.14 |
-0.61 |
0.09 |
-4.32 |
-0.78 |
-1.39 |
-5.05 |
0.03 |
| EPS |
0.82 |
0.26 |
-0.18 |
-0.54 |
0.1 |
-1.25 |
-0.72 |
-1.12 |
-1.51 |
0.05 |
| EPS Diluted |
0.82 |
0.24 |
-0.18 |
-0.54 |
0.09 |
-1.25 |
-0.72 |
-1.12 |
-1.51 |
0.05 |
| Weighted Average Shares
Out |
$103.29 M
|
$99.83 M
|
$83.21 M
|
$63.17 M
|
$55.36 M
|
$53.68 M
|
$52.38 M
|
$48.36 M
|
$37.94 M
|
$30.55 M
|
| Weighted Average Shares
Out Diluted |
$103.29 M
|
$105.06 M
|
$83.21 M
|
$63.17 M
|
$56.40 M
|
$53.68 M
|
$52.38 M
|
$48.36 M
|
$37.94 M
|
$30.69 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
